Skip to Content
Menu
About
Science
EDO Platform
Scientific Publications
Pipeline
Overview
Clinical Trials
Expanded Access Policy
Careers
Investors
News
Contact
PGN-EDODM1, in Development for Myotonic Dystrophy Type 1
Post navigation
Previous:
FREEDOM-DM1: A Phase 1, Placebo-Controlled Single Ascending Dose Study to Evaluate PGN-EDODM1 in People with Myotonic Dystrophy Type 1 (DM1)
Next:
PGN-EDODM1 in Development for Myotonic Dystrophy Type 1
